These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 24934596)

  • 1. Myasthenia Gravis: paradox versus paradigm in autoimmunity.
    Berrih-Aknin S
    J Autoimmun; 2014 Aug; 52():1-28. PubMed ID: 24934596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myasthenia gravis: a comprehensive review of immune dysregulation and etiological mechanisms.
    Berrih-Aknin S; Le Panse R
    J Autoimmun; 2014 Aug; 52():90-100. PubMed ID: 24389034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiological mechanisms of autoimmunity.
    Sudres M; Verdier J; Truffault F; Le Panse R; Berrih-Aknin S
    Ann N Y Acad Sci; 2018 Feb; 1413(1):59-68. PubMed ID: 29377165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The thymus in autoimmune Myasthenia Gravis: Paradigm for a tertiary lymphoid organ.
    Weiss JM; Cufi P; Le Panse R; Berrih-Aknin S
    Rev Neurol (Paris); 2013; 169(8-9):640-9. PubMed ID: 24008049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmune mechanisms in myasthenia gravis.
    Cavalcante P; Bernasconi P; Mantegazza R
    Curr Opin Neurol; 2012 Oct; 25(5):621-9. PubMed ID: 22941261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights in the autoimmunity of myasthenia gravis.
    De Baets MH
    Autoimmunity; 2010 Aug; 43(5-6):341-3. PubMed ID: 20380585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune associations and autoantibody screening show focused recognition in patient subgroups with generalized myasthenia gravis.
    Klein R; Marx A; Ströbel P; Schalke B; Nix W; Willcox N
    Hum Immunol; 2013 Sep; 74(9):1184-93. PubMed ID: 23792059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenic immune mechanisms at the neuromuscular synapse: the role of specific antibody-binding epitopes in myasthenia gravis.
    Huijbers MG; Lipka AF; Plomp JJ; Niks EH; van der Maarel SM; Verschuuren JJ
    J Intern Med; 2014 Jan; 275(1):12-26. PubMed ID: 24215230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innate immunity in myasthenia gravis thymus: pathogenic effects of Toll-like receptor 4 signaling on autoimmunity.
    Cordiglieri C; Marolda R; Franzi S; Cappelletti C; Giardina C; Motta T; Baggi F; Bernasconi P; Mantegazza R; Cavalcante P
    J Autoimmun; 2014 Aug; 52():74-89. PubMed ID: 24397961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymic remodeling associated with hyperplasia in myasthenia gravis.
    Le Panse R; Bismuth J; Cizeron-Clairac G; Weiss JM; Cufi P; Dartevelle P; De Rosbo NK; Berrih-Aknin S
    Autoimmunity; 2010 Aug; 43(5-6):401-12. PubMed ID: 20402580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonal heterogeneity of thymic B cells from early-onset myasthenia gravis patients with antibodies against the acetylcholine receptor.
    Vrolix K; Fraussen J; Losen M; Stevens J; Lazaridis K; Molenaar PC; Somers V; Bracho MA; Le Panse R; Stinissen P; Berrih-Aknin S; Maessen JG; Van Garsse L; Buurman WA; Tzartos SJ; De Baets MH; Martinez-Martinez P
    J Autoimmun; 2014 Aug; 52():101-12. PubMed ID: 24439114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune myasthenia gravis: autoantibody mechanisms and new developments on immune regulation.
    Le Panse R; Berrih-Aknin S
    Curr Opin Neurol; 2013 Oct; 26(5):569-76. PubMed ID: 23995274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An imbalance between regulatory T cells and T helper 17 cells in acetylcholine receptor-positive myasthenia gravis patients.
    Villegas JA; Van Wassenhove J; Le Panse R; Berrih-Aknin S; Dragin N
    Ann N Y Acad Sci; 2018 Feb; 1413(1):154-162. PubMed ID: 29405352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and biological heterogeneity of autoimmune myasthenia gravis.
    Pal J; Rozsa C; Komoly S; Illes Z
    J Neuroimmunol; 2011 Feb; 231(1-2):43-54. PubMed ID: 21093931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The thymus in myasthenia gravis: Site of "innate autoimmunity"?
    Cavalcante P; Le Panse R; Berrih-Aknin S; Maggi L; Antozzi C; Baggi F; Bernasconi P; Mantegazza R
    Muscle Nerve; 2011 Oct; 44(4):467-84. PubMed ID: 21922466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary immunodeficiency and autoimmunity: lessons from human diseases.
    Arason GJ; Jorgensen GH; Ludviksson BR
    Scand J Immunol; 2010 May; 71(5):317-28. PubMed ID: 20500682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental myasthenia gravis in Aire-deficient mice: a link between Aire and regulatory T cells.
    Aricha R; Feferman T; Berrih-Aknin S; Fuchs S; Souroujon MC
    Ann N Y Acad Sci; 2012 Dec; 1275():107-13. PubMed ID: 23278585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ectopic germinal centers, BAFF and anti-B-cell therapy in myasthenia gravis.
    Berrih-Aknin S; Ragheb S; Le Panse R; Lisak RP
    Autoimmun Rev; 2013 Jul; 12(9):885-93. PubMed ID: 23537509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of T regulatory cells in immunopathogenesis of myasthenia gravis: implications for therapeutics.
    Alahgholi-Hajibehzad M; Kasapoglu P; Jafari R; Rezaei N
    Expert Rev Clin Immunol; 2015; 11(7):859-70. PubMed ID: 25973691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myasthenia gravis and the neuromuscular junction.
    Querol L; Illa I
    Curr Opin Neurol; 2013 Oct; 26(5):459-65. PubMed ID: 23945282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.